Soterix Medical has announced the launch of the MxN-GO EEG system that integrates high-definition transcranial electrical stimulation (HD-tES) with EEG capabilities.
This system is designed to facilitate research applications that require both electrical brain stimulation and activity recording in mobile and natural settings.
The MxN-GO EEG system has a wire-free, lightweight design that simplifies setup and enhances user comfort.
It features 33 stimulation channels and 32 recording channels, offering high precision and targeted application-specific functionality.
The development of the MxN-GO EEG system is a result of a collaboration between Soterix Medical and mBrainTrain, a specialist in mobile EEG solutions.
Together, they have created the tool for conducting mobile hybrid stimulation and EEG studies.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSoterix Medical CEO Dr Abhishek Datta said: 鈥淪oterix Medical was founded in 2008 to develop HD-tES as the first transcranial system capable of brain targeting with weak electrical stimulation.
鈥淭he MxN-GO EEG solution combines into one product our 16 years of leadership and innovation in High-Definition with the unmatched mobile EEG collection expertise of mBrainTrain.鈥�
鈥淩esearchers and clinician-scientists recognise that brain science and medicine advancements increasingly depend on combining brain modulation and recording. Moreover, that reproducibility and rigour absolutely depend on the quality of the equipment used.鈥�
Soterix Medical鈥檚 HD-tES is enabled by advanced electrode design, which facilitates the safe and well-tolerated delivery of electrical currents through ‘High-Definition’ electrodes.
The technology also incorporates individualised brain current-flow modelling and in-house targeting algorithms that guide the placement and activation of HD electrodes on the head.
In August 2023, Soterix Medical initiated the Phase II RECOVER-NEURO clinical study to evaluate the effectiveness of combining REMOTE-tDCS with a brain training programme to treat long Covid.
The study was conducted through NYU Langone Health’s home-based remotely supervised tDCS programme, which is accessible to patients across the US.
